InsidersTradesSigma
Track the 씨어스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 씨어스 has published 13 reports. Market capitalisation: €915.3bn. The latest transaction was reported on 10 April 2026 (Purchase). Among the most active insiders: 채정훈. All data is free.
6
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,359 of 29,064 companies
60.4
score / 100
Value29
Quality92
FCF yld0.1%
Earn yld2.0%
EV/EBITDA45.8x
ROE80%
Gross mgn72%
Net mgn33%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 April 2026
Declarations13 total
Other
Other
Other
Other
Other
Other
Other
13 of 13 declarations
关于 씨어스
씨어스 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。它专注于药品的开发和商业化。